WRAL Tech Wire

Liquidia Technologies hires another J&J executive for production role

Venture-backed Liquidia Technologies is expanding its management team with a new vice president for its supply chain management.

Taking the position is Thomas Templeman, who most recently was general manager at Centocor Biologics. Centocor is part of Johnson & Johnson.

Liquidia is focused on proprietary nanotechnology for use in medicine and vaccine delivery as well as other users.

“Dr. Templeman brings to Liquidia a diverse array of clinical and commercial manufacturing experience,” said Liquidia Chief Executive Officer Neal Fowler. “He also has extensive knowledge in regulatory compliance and shares our passion for bringing safer and more effective therapies to market.”

Fowler also worked for Johnson & Johnson as did his predecessor, Todd Pope. He was president at Centocor before taking the Liquidia position. Pope left Liquidia to return to J&J.

Liquidia's technology is based on materials known as fluoropolymers that are liquids at room temperature but cure to transparent solids when exposed to lights. Liquidia has developed a material platform technology called Fluorocur, which enables the mass production of precise and uniform micro-sized and nano-sized particles. Fluorocur is based on research done at UNC Chapel Hill and NCSU by Joe DeSimone. DeSimone has been involved in entrepreneurial ventures in the past, including the launching of a chain of dry cleaners that did not rely on chemicals. In 1996, he launched Micell Technologies, which focused on using carbon dioxide as a solvent.

Liquidia has raised $22 million in venture financing.

Venture & Innovation

Stories about local business ventures and innovation. Read more articles…